Codexis Stock Analysis
| CDXS Stock | USD 1.61 0.02 1.23% |
Codexis holds a debt-to-equity ratio of 0.289. Codexis' financial risk is the risk to Codexis stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Codexis' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Codexis' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Codexis Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Codexis' stakeholders.
For most companies, including Codexis, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Codexis, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Codexis' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Codexis' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Codexis is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Codexis to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Codexis is said to be less leveraged. If creditors hold a majority of Codexis' assets, the Company is said to be highly leveraged.
Codexis is undervalued with Real Value of 2.82 and Hype Value of 1.7. The main objective of Codexis stock analysis is to determine its intrinsic value, which is an estimate of what Codexis is worth, separate from its market price. There are two main types of Codexis' stock analysis: fundamental analysis and technical analysis.
The Codexis stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Codexis is usually not traded on Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday. Codexis Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Codexis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. Codexis Stock Analysis Notes
About 70.0% of the company shares are held by institutions such as insurance companies. The book value of Codexis was currently reported as 0.43. The company recorded a loss per share of 0.73. Codexis had not issued any dividends in recent years. Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people. For more info on Codexis please contact Stephen MBBS at 650 421 8100 or go to https://www.codexis.com.Codexis Investment Alerts
| Codexis generated a negative expected return over the last 90 days | |
| Codexis may become a speculative penny stock | |
| Codexis has high historical volatility and very poor performance | |
| Codexis has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 59.34 M. Net Loss for the year was (65.28 M) with loss before overhead, payroll, taxes, and interest of (10.7 M). | |
| Codexis currently holds about 90.11 M in cash with (49.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. | |
| Codexis has a frail financial position based on the latest SEC disclosures | |
| Roughly 70.0% of the company shares are held by institutions such as insurance companies |
Codexis Upcoming and Recent Events
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Codexis Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 145.42 M.Codexis Profitablity
The company has Profit Margin (PM) of (1.21) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.2) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.2.Technical Drivers
As of the 4th of January, Codexis shows the mean deviation of 3.42, and Risk Adjusted Performance of (0.10). Codexis technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Codexis market risk adjusted performance and treynor ratio to decide if Codexis is priced correctly, providing market reflects its regular price of 1.61 per share. Please also double-check Codexis jensen alpha, which is currently at (0.77) to validate the company can sustain itself at a future point.Codexis Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Codexis for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Codexis short-term fluctuations and highlight longer-term trends or cycles.
Codexis Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Codexis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Codexis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Codexis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Codexis Outstanding Bonds
Codexis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Codexis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Codexis bonds can be classified according to their maturity, which is the date when Codexis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Codexis Predictive Daily Indicators
Codexis intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Codexis stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Codexis Forecast Models
Codexis' time-series forecasting models are one of many Codexis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Codexis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Codexis Bond Ratings
Codexis financial ratings play a critical role in determining how much Codexis have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Codexis' borrowing costs.| Piotroski F Score | 3 | Frail | View |
| Beneish M Score | (3.31) | Unlikely Manipulator | View |
Codexis Debt to Cash Allocation
Many companies such as Codexis, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Codexis currently holds 59.9 M in liabilities with Debt to Equity (D/E) ratio of 0.29, which may suggest the company is not taking enough advantage from borrowing. Codexis has a current ratio of 4.74, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Codexis' use of debt, we should always consider it together with its cash and equity.Codexis Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Codexis' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Codexis, which in turn will lower the firm's financial flexibility.Codexis Corporate Bonds Issued
About Codexis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Codexis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Codexis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Codexis. By using and applying Codexis Stock analysis, traders can create a robust methodology for identifying Codexis entry and exit points for their positions.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Codexis to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.